SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-18-061387
Filing Date
2018-10-10
Accepted
2018-10-10 16:49:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D a18-36543_2sc13d.htm SC 13D 131921
  Complete submission text file 0001104659-18-061387.txt   133427
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filed by) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D

Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Subject) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-90671 | Film No.: 181116413
SIC: 2834 Pharmaceutical Preparations